Home > News > Valensa Appoints Dr. Rudi E. Moerck President
May 23rd, 2006
Valensa Appoints Dr. Rudi E. Moerck President
Abstract:
Valensa International has appointed Dr. Rudi E. Moerck as President. In his new role, Dr. Moerck will
lead both the technology development and new product commercialization efforts for the company, which already offers innovative natural botanical-sourced products such as ZANTHIN(R) astaxanthin, USPlus Saw Palmetto, CRANBEROL(R) cranberry seed extract and more.
Source:
prnewswire
Bookmark:
Valensa International
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Appointments/Promotions/New hires/Resignations/Deaths
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
SEMATECH Names William R. Rozich Chairman of the Board June 13th, 2013
David Neuschuler Joins RASIRC to Manage Engineering June 3rd, 2013
Asylum Research Announces Ben Ohler as AFM Business Manager May 29th, 2013